Last edition
News about Global Pharma
Bristol Myers Squibb Acquires RayzeBio for USD 4.1 Billion
RayzeBio specializes in developing radioactive drugs targeting various tumors in organs such as the lung, pancreas, and liver.
Global Pharma | 30/12/2023 | By Manvi | 786
Silo Pharma Gets Nod to Develop Ketamine Implant for Fibromyalgia
In collaboration with Sever Pharma Solutions, Silo's development partner, SP-26 is undergoing crucial analytical testing and pre-clinical trials.
Global Pharma | 29/12/2023 | By Manvi | 432
Union Health Minister Launches Critical Care Blocks and Labs in Andhra Pradesh
The new facilities are poised to enhance Andhra Pradesh's healthcare infrastructure, providing a substantial response to health emergencies.
Global Pharma | 29/12/2023 | By Manvi | 522
Eugia Pharma Specialities Ltd Gets USFDA Final Approval for Posaconazole Injection
The product is expected to be launched in December 2023. The approved product has an estimated market size of USD 25.4 million for the twelve months ending October 2023, according to IQVIA.
Global Pharma | 28/12/2023 | By Manvi | 1371
Sanjivani Paranteral Raises Funds through Issuance of Warrants & Preferential Allotment
The company also approved preferential allotment of 16,86,000 equity shares at Rs 135.10 per share, amounting to Rs 22.77 crores to non-promoter investors.
Global Pharma | 28/12/2023 | By Manvi | 1017
The product will be manufactured at Lupin’s Pithampur facility in India. Loteprednol Etabonate Ophthalmic Suspension, 0.2%, is indicated for the temporary relief of the signs and symptoms of seasonal allergic conjunctivitis.
Global Pharma | 28/12/2023 | By Manvi | 790
PharmaBlock Opens HPAPI GMP Facility at Zhejiang Manufacturing Site
PharmaBlock Sciences (Nanjing), Inc. has announced opening of a new high potency API (HPAPI) GMP facility (OEB-5 and above) at its Zhejiang manufacturing site.
Global Pharma | 28/12/2023 | By Manvi | 641
Under this strategic collaboration, Menarini India has obtained exclusive rights to market and distribute the dermo-cosmetic brands, EAU THERMALE AVÈNE and DUCRAY in India.
Global Pharma | 27/12/2023 | By Manvi | 1335
AstraZeneca to Buy China-Based Gracell Biotechnologies in USD 1.2 Billion Deal
The cash deal aimed at bolstering AstraZeneca's portfolio values US listed Gracell at $2 per ordinary share or USD 10 per ADS of Gracell, plus a non-tradable contingent value right of USD 0.30 per ordinary share, if certain regulatory milestones are met.
Global Pharma | 27/12/2023 | By Manvi | 692
Four Workers Hospitalised After Inhaling Toxic Gas at Pharma Chemical Factory
Four workers were hospitalised after they inhaled toxic gas leaking from a pipe at a pharmaceutical chemical company in Vadodara city of Gujarat, police said.
Global Pharma | 27/12/2023 | By Manvi | 554
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy